Skip to main content

Table 3 suPAR concentrations and blood eosinophil count in 1341 patients with asthma following an acute hospital admission

From: The biomarkers suPAR and blood eosinophils are associated with hospital readmissions and mortality in asthma – a retrospective cohort study

 

No event

Readmitted

P-value

Died

P-value

30-day follow-up

 suPAR (ng/mL)

2.5 (1.9–3.3)

3.1 (2.1–4.1)

< 0.0001

5.6 (3.6–7.7)

< 0.0001

 Blood eosinophil count (cells/μL)

190 (70–420)

160 (60–340)

0.088

20 (0–50)

< 0.0001

90-day follow-up

 suPAR (ng/mL)

2.5 (1.9–3.3)

2.8 (2.0–3.9)

0.0002

5.7 (3.5–7.7)

< 0.0001

 Blood eosinophil count

(cells/μL)

200 (70–430)

150 (60–320)

0.024

30 (10–150)

< 0.0001

365-day follow-up*

 suPAR (ng/mL)

2.4 (1.8–3.1)

2.6 (2.0–3.7)

< 0.0002

5.1 (3.4–7.4)

< 0.0001

 Blood eosinophil count

(cells/μL)

200 (80–450)

160 (60–340)

0.0031

30 (10–130)

< 0.0001

  1. Values presented as percentages or median (interquartile range)
  2. *Only patients with 365 days follow-up included in analyses (n = 1068)
  3. suPAR - Soluble Urokinase Plasminogen Activator Receptor